Sibirioside A

CAS No. 173046-19-0

Sibirioside A( ——— )

Catalog No. M38863 CAS No. 173046-19-0

Sibirioside A is a phenylpropanoid glycoside isolated fromScrophulariae Radix.Sibirioside A has the potential for the treatment of diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 308 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sibirioside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Sibirioside A is a phenylpropanoid glycoside isolated fromScrophulariae Radix.Sibirioside A has the potential for the treatment of diabetes.
  • Description
    Sibirioside A is a natural product
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    173046-19-0
  • Formula Weight
    472.44
  • Molecular Formula
    C21H28O12
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang YF, et al. Investigation of the In Vivo Metabolism of Sibirioside A and Angoroside C in Rats by HPLC-ESI-IT-TOF-MSn.Molecules. 2018 Oct 19;23(10).?
molnova catalog
related products
  • D-(-)-Tartaric acid

    D-Tartaric acid also known as (SS)-tartarate or D-threaric acid belongs to the class of organic compounds known as sugar acids and derivatives.

  • NADPH tetrasodium sa...

    NADPH tetrasodium salt is the reduced form of the electron acceptor nicotinamide adenine dinucleotide phosphate (NADP+) and acts as an electron donor in various biological reactions.

  • Relatlimab

    Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.